$ Value
$0
Shares
53,521
Price
$0
Filed
Oct 27
Insider
Name
Xu Diyong
Title
—
CIK
0001995088
Roles
Transaction Details
Transaction Date
2025-10-23
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
53,521
Footnotes
The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) October 23, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date. | Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VII, LP.
Filing Info
Xu Diyong's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-10-23 | QTTB | A | $0 |
Other Insiders at QTTB (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| LAPORTE KATHLEEN | — | — | 2026-01-15 |
|
Morrison Jodie Pope
CEO
|
— | $45K | 2026-02-25 |
|
Kalowski Lee
CFO and President
|
— | $18K | 2026-02-25 |
| Lundberg Sven Ante | — | — | 2026-01-15 |
| GRAYZEL DAVID S. | — | — | 2026-01-15 |
|
Violette Shelia M.
Chief Scientific Officer
|
— | $13K | 2026-02-25 |